Q4 2021 Holdings
Filed 2022-02-14 | 186 holdings | $78.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $37.3M | 613,126 | 47.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $16.2M | 419,216 | 20.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.1M | 29,533 | 9.1% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $4.7M | 196,408 | 6.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.7M | 970,398 | 4.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $2.8M | 544,819 | 3.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $1.9M | 82,335 | 2.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.2M | 482,610 | 1.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 8,400 | 1.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $801.0K | 150,484 | 1.0% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $262.0K | 35,048 | 0.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $222.0K | 70,000 | 0.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $204.0K | 1,195 | 0.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $156.0K | 10,785 | 0.2% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $60.7K | 542,400 | 0.1% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $36.0K | 399,400 | 0.0% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $30.2K | 178,300 | 0.0% |
| Horizon Therapeutics PUB LCall | SHS | G46188101 | $26.6K | 246,900 | 0.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $25.0K | 1,500 | 0.0% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $22.9K | 593,800 | 0.0% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $17.4K | 451,200 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $17.1K | 1,020,917 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $16.1K | 191,140 | 0.0% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $15.2K | 909,700 | 0.0% |
| Kodiak Sciences Inc(KOD)Call | COM | 50015M109 | $14.2K | 167,900 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $13.2K | 1,166,933 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $12.4K | 569,029 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $11.5K | 1,750,043 | 0.0% |
| Athira Pharma IncCall | COM | 04746L104 | $11.2K | 860,000 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $10.3K | 92,400 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $9.9K | 737,546 | 0.0% |
| Zogenix IncCall | COM NEW | 98978L204 | $9.6K | 590,400 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $9.5K | 200,000 | 0.0% |
| Biomarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $8.8K | 100,000 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $8.4K | 477,418 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $8.2K | 75,661 | 0.0% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $7.5K | 2,691,110 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.0K | 295,111 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $6.6K | 795,903 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $6.5K | 400,000 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $6.5K | 149,850 | 0.0% |
| Ayala Pharmaceuticals Inc | COM | 05465V108 | $5.7K | 669,271 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.6K | 179,138 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $5.3K | 200,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.2K | 2,264,491 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $5.1K | 795,410 | 0.0% |
| Arcus Biosciences Inc(RCUS)Put | COM | 03969F109 | $5.0K | 124,600 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.9K | 86,865 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $4.8K | 164,082 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $4.5K | 901,362 | 0.0% |